Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-30 @ 11:36 PM
Study NCT ID:
NCT06401603
Status:
RECRUITING
Last Update Posted:
2025-09-11
First Post:
2024-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-02
First Submit QC Date:
None
Study First Post Date:
2024-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-05
Last Update Post Date:
2025-09-11
Last Update Post Date Type:
ESTIMATED